1 option
Valeant Pharmaceuticals' Business Model: The Repercussions for Patients and the Health Care System: Hearing Before the Special Committee on Aging, U.S. Senate, One Hundred Fourteenth Congress, Second Session [2016]
- Format:
- Book
- Language:
- English
- Other Title:
- Valeant Pharmaceuticals' Business Model
- Place of Publication:
- U.S. Government Publishing Office
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.